Every Disease Has its Day
October 31, 2022
Is now finally the time for Alzheimer’s drug development to shine?
2 min read
False
Advertisement
Oct
From Viral Video to Magic Medicine
October 28, 2022
In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy
2 min read
Video Roundtable: Pharma Trends & Events Post-COVID-19
October 27, 2022
Watch our roundtable discussion featuring experts from Roquette, Bioiberica, PCI Pharma Services, and Avantor
1 min read
The Nucleic Acid Revolution
October 26, 2022
Will nucleic acid medicine transform advanced therapy?
3 min read
Business & Trends
Small Molecules
Bioprocessing
Biopharma
Cell & Gene
Outsourcing
Technology & Manufacturing
Who Are the Best Companies in the Pharma Field?
October 24, 2022
Voting is now open for the Company of the Year Awards – make sure you have your say!
2 min read
Memories From the Start of the Gene Therapy Wave
October 21, 2022
The remarkable story of gene therapy drug development during the 1990s and early 2000s
10 min read
De-Risking Your Sterile Manufacturing Program
October 21, 2022
Drug development program sponsors are increasingly looking to CDMOs to help reduce risk and push projects forward. With more than 40 years of experience, Alcami knows how to minimize risk at every single step of the development path.
6 min read
Let’s Get Closer
October 20, 2022
Post-COVID-19, the pharma industry has a better opportunity than ever before to get closer to the patient
4 min read
The Dual Sourcing Approach
October 20, 2022
How robust is your strategy? Are you prepared for supply chain interruption? In today’s turbulent world, risk mitigation strategies are a must – and having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines is no longer a ‘nice to have’. It should be an essential part of your strategy in terms of patient health.
1 min read
Scoping Out the Future of Single Use – Together
October 19, 2022
Cytiva’s single-use and fluid management technologies were deployed in the production of vaccines and treatments to fight the COVID-19 pandemic. Now, the company is keen to work collaboratively to apply lessons learned – and address increasing demand for flexibility and component interchangeability.
6 min read
Browse by Topics
Interviews
Cell & Gene
Bioprocessing
Drug Delivery
Drug Discovery
Development & Clinical
Formulation
Facilities & Equipment
Outsourcing
Packaging
Regulation & Standards
Small Molecules
Supply Chain
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blogs